Privi Speciality Chemicals announced a robust performance for Q2 and H1 FY27, showcasing strong financial growth driven by broad-based demand. The company reported significant year-on-year increases in total income, EBITDA, and net profit. The presentation also outlines strategic growth initiatives, including expansion projects set for completion in 2028 and a vision to achieve Rs 5,000 Cr revenue by FY29-30.
Privi Speciality Chemicals Unveils Strong Q2 & H1 FY27 Performance
Privi Speciality Chemicals Limited has released its investor presentation for the quarter and half-year ended September 30, 2026, highlighting a period of significant momentum and resilience amidst challenging global headwinds. The company underscored its strong financial performance, attributing it to a robust business model and disciplined execution.
Key Financial Highlights
For Q2 FY27, Privi Speciality Chemicals reported:
- Total Income: Rs 773.16 Crore, a 13.90% year-on-year growth.
- EBITDA: Rs 212.49 Crore, marking a 16.66% year-on-year increase.
- Net Profit: Rs 117.03 Crore, reflecting a substantial 24.61% year-on-year growth.
The consolidated performance for H1 FY27 also demonstrated strong growth, with Total Income of Rs 1,454.59 Cr (+16.7% YoY), EBITDA of Rs 379.96 Cr (+17.6% YoY), and PAT of Rs 201.23 Cr (+29.1% YoY).
Balance Sheet and Returns
The company reported healthy financial metrics as of September 30, 2026:
- ROCE: 24.30% (+216 bps YoY improvement).
- ROE: 26.34% (+134 bps YoY improvement).
- Net Debt to EBITDA: 1.07x (32.1% YoY improvement).
- Net Debt to Equity: 0.51x (37.9% YoY improvement).
Strategic Growth Initiatives
Privi Speciality Chemicals is actively pursuing a strategic growth roadmap, including:
- Expansion Projects: Currently progressing as planned, these projects are slated for commercial operations in the second half of 2028.
- New Products: Expected to expand the company’s addressable market and deepen customer relationships.
- Vision 5k | 1k Milestone: The company is on track to achieve a vision of Rs 5,000 Cr revenue and Rs 1,000 Cr+ EBITDA by FY29-30, representing more than a 2x growth.
- EBITDA Margins: Expected to sustain north of 20%, driven by operational efficiency and an enhanced product mix.
The company also highlighted its diversified geographic presence, which has supported stability across markets, and a strong balance sheet with healthy cash flows, positioning it well for future opportunities.
Source: BSE
